<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00791882</url>
  </required_header>
  <id_info>
    <org_study_id>SST</org_study_id>
    <nct_id>NCT00791882</nct_id>
  </id_info>
  <brief_title>Social Skills Training in Refractory Schizophrenia</brief_title>
  <acronym>SST</acronym>
  <official_title>Evaluation of Social Skills Training in Reducing Negative Symptoms in Patients With Refractory Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective Primary:&#xD;
&#xD;
      To evaluate the efficacy of social skills training in reducing negative symptoms in patients&#xD;
      with refractory schizophrenia, in comparison with control (befriending group).&#xD;
&#xD;
      Secondary:&#xD;
&#xD;
      To evaluate changes in social functioning.&#xD;
&#xD;
      To evaluate the effect of SST in other dimensions of psychopathology: positive symptoms,&#xD;
      depression and general psychopathology.&#xD;
&#xD;
      To evaluate the impact of SST in cognition.&#xD;
&#xD;
      Hypothesis Social skills training is more effective than control group (Befriending) in&#xD;
      reducing negative symptoms in patients with refractory schizophrenia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In schizophrenia positive symptoms can be improved with an antipsychotic treatment. However&#xD;
      there is a subgroup of patients who have a predominance of persistent negative symptoms that&#xD;
      do not respond to antipsychotic treatment, such as blunted affect , emotional and social&#xD;
      withdrawal, and there is evidence that such symptoms can improve with psychosocial&#xD;
      interventions.&#xD;
&#xD;
      The objective of this study is to evaluate the efficacy of Social Skills Training on negative&#xD;
      symptoms in patients with refractory schizophrenia by means of a randomized, single-blind&#xD;
      controlled trial with the duration of a year, including, follow up.&#xD;
&#xD;
      This study will be conducted in two groups: one group will receive social skills training&#xD;
      (N=46) and a control group (N=46) will attend the same number of sessions, but without&#xD;
      intervention of the therapists (befriending).&#xD;
&#xD;
      Psychiatric, psychological and neuropsychological aspects will be evaluated at baseline,&#xD;
      after 20 weeks and 6 months after the end of the intervention.&#xD;
&#xD;
      The scales that will be used for the psychiatric assessments are: PANSS (reduction of 20% in&#xD;
      the negative subscale), CGI, CALGARY, SDS, and PSP, As well as the Social Skills Inventory&#xD;
      IHS. The neuropsychological assessment will have groups of scales to measure: Attention,&#xD;
      Memory, Executive Functions, Estimated Intellectual Efficiency and a ToM. For statistical ,&#xD;
      the repeated measure ANOVA will be used, as well as the effect size and number needed to&#xD;
      treat.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2009</start_date>
  <completion_date type="Anticipated">August 2011</completion_date>
  <primary_completion_date type="Anticipated">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Response: at least 20% decrease at PANSS - negative subscale after 20 weeks, in comparison with baseline, maintained at 26 weeks follow-up.</measure>
    <time_frame>20 weeks treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement at PSP scores</measure>
    <time_frame>20 weeks after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">92</enrollment>
  <condition>Schizophrenia and Disorders With Psychotic Features</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group of behaviors by which someone express feelings, attitudes, wishes,opinions and rights , in an adequate manner regarding situation and context.&#xD;
Social skills are the substrate for social competence, which is the ability to find and legitimate relevant and personal goals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group will attend the same number of sessions, but without intervention of the therapists</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Social Skills Training</intervention_name>
    <description>A program developed during 20 weeks according to adapted BELLACK 's manual (1997),including sessions in group one hour per week.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <other_name>Social Skills Training and Control group without active intervention.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of schizophrenia can´t not be over 10 years old.&#xD;
&#xD;
          -  Age between 18 and 55 years old.&#xD;
&#xD;
          -  A minimum of 16 in negative subscale of PANSS.&#xD;
&#xD;
          -  A score 4 in at least 3 of the following symptoms:&#xD;
&#xD;
               -  blunted affect&#xD;
&#xD;
               -  social withdrawal&#xD;
&#xD;
               -  rapport&#xD;
&#xD;
               -  passive social withdrawal&#xD;
&#xD;
               -  lack of spontaneity&#xD;
&#xD;
               -  motor retardation&#xD;
&#xD;
               -  active social avoidance&#xD;
&#xD;
          -  Stable disease, in use of clozapine, without recent hospitalization.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Comorbid substance use.&#xD;
&#xD;
          -  Axis I comorbidity.&#xD;
&#xD;
          -  History of head trauma or neurological disease.&#xD;
&#xD;
          -  Clinical problems which can affect central nervous system.&#xD;
&#xD;
          -  Mental retardation.&#xD;
&#xD;
          -  Patients treated with other antipsychotic than clozapine.&#xD;
&#xD;
          -  Patients who underwent other psychosocial treatments.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helio Elkis, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Departamento de Psiquiatria da FMUSP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Helio Elkis, MD PhD</last_name>
    <phone>+ 55 11 30697531</phone>
    <email>helkis@usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Silvia Scemes, BSc</last_name>
    <phone>+ 55 11 30697808</phone>
    <email>silviascemes@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto de Psiquiatria do HCFMUSP</name>
      <address>
        <city>São Paulo</city>
        <zip>05403000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Scemes, BSc</last_name>
      <phone>55 11 30697808</phone>
      <email>silviascemes@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Helio Elkis, PhD MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <study_first_submitted>November 14, 2008</study_first_submitted>
  <study_first_submitted_qc>November 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2008</study_first_posted>
  <last_update_submitted>November 27, 2009</last_update_submitted>
  <last_update_submitted_qc>November 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 30, 2009</last_update_posted>
  <responsible_party>
    <name_title>Helio Elkis MD PhD</name_title>
    <organization>Instituto de Psiquiatria da Faculdade de Medicina da Universidade de São Paulo</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Schizophrenia Spectrum and Other Psychotic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

